Takeda’s off-the-shelf stem cell therapy closes in on EU approval – BioPharma-Reporter.com
BioPharma-Reporter.com |
Takeda's off-the-shelf stem cell therapy closes in on EU approval
BioPharma-Reporter.com The EMA has recommended approval of the first ever off-the-shelf stem cell therapy, Takeda and Tigenix's Alofisel (darvadstrocel). The European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorisation of the candidate … Is Buying All-time Stock Like TiGenix NV (TIG) a Winning Strategy? |
